Synchrony Financial Expands Partnership with Planet DDS
Synchrony Financial's stock fell 4.66% as it hit a 20-day low amid broader market declines, with the Nasdaq-100 down 0.80% and the S&P 500 down 0.68%.
The decline occurred despite Synchrony announcing an expansion of its strategic partnership with Planet DDS, making CareCredit the preferred financing solution across all Planet DDS platforms. This integration is expected to enhance patient financing accessibility and streamline financial processes for over 2,500 orthodontic practices, marking a significant innovation in their service offerings.
This partnership reflects Synchrony's commitment to leveraging technology in healthcare financing, which could improve operational efficiency and patient experience. However, the stock's performance is overshadowed by the overall market weakness, indicating a potential sector rotation affecting financial stocks.
Trade with 70% Backtested Accuracy
Analyst Views on SYF
About SYF
About the author

- Earnings Season Significance: Wall Street is set for a packed earnings season featuring key companies like Capital One and Boeing, with investors eager to glean insights into the economic impact of the Iran war from these reports.
- Capital One Performance Focus: Capital One is scheduled to report earnings on Tuesday, with market attention on its consumer health metrics and the progress of its acquisitions of Discover and Brex, particularly amid rising economic uncertainties.
- Boeing Earnings Outlook: Boeing is expected to release its earnings report on Wednesday, with market focus on order volumes in both its commercial and defense sectors, as well as free cash flow performance, especially after previous unexpected losses.
- GE Vernova Order Growth: GE Vernova will report alongside Boeing, with first-quarter new orders anticipated to reach $14.4 billion, reflecting a 65% year-over-year increase, indicating strong market performance amid rising electricity demand.
- Market Performance Review: The three major indexes surged this week, with the S&P 500 recording its largest one-week gain since May, while the information technology sector climbed 8%, indicating a strong market rebound.
- Overbought Signals: Following the significant market gains, CNBC Pro screened for overbought stocks, with AMD's relative strength index (RSI) exceeding 80, as shares jumped over 13% this week, suggesting potential short-term pullback risks.
- Analyst Ratings Optimistic: Despite concerns of a pullback, most analysts polled by FactSet maintain a buy rating for AMD, expecting about 5% more upside, reflecting confidence in its long-term performance.
- Other Stock Performances: In addition to AMD, ON Semiconductor, Intel, and Broadcom also showed strong performances with RSIs in the high 70s, while Synchrony Financial's RSI approached 74, indicating potential for an 8% increase over the next year despite a year-to-date decline of over 6%.
- Market Rebound: The S&P 500 and Nasdaq Composite reached all-time highs this week, with the S&P 500 surpassing 7,100 for the first time, reflecting strong investor confidence in economic recovery and suggesting further upward momentum for equities.
- Earnings Expectations: According to FactSet, the S&P 500 is projected to have a blended growth rate of 12.5% in Q1, with 78% of reporting companies exceeding expectations, providing a positive backdrop for the upcoming earnings season that could further bolster market confidence.
- Oil Price Volatility: While oil prices have fallen to around $80 per barrel, significantly below the $110 peak during the conflict, the market must remain vigilant regarding the potential impacts of U.S.-Iran tensions on global supply chains, particularly concerning the safety of transit through the Strait of Hormuz.
- Technical Fragility: Despite the market's strong short-term performance, analyst Craig Johnson warns that the rapid transition from oversold to overbought conditions masks underlying macroeconomic risks, urging investors to remain cautious and focus on high-quality investment opportunities.
- New Financing Solution: Synchrony has launched the RH Credit Card to provide flexible financing options for RH customers, supporting their purchases of luxury home furnishings at RH galleries, outlets, and RH.com, thereby enhancing the shopping experience and driving sales growth.
- Member Exclusive Benefits: The RH Credit Card is fully integrated with the RH Members Program, allowing members to enjoy 30% savings on all purchases and exclusive interior design services, which further enhances customer loyalty and attracts more high-end consumers.
- Fast Application Process: The credit application process is seamlessly integrated across channels, enabling customers to receive credit decisions in minutes, which will improve customer satisfaction and accelerate purchasing decisions.
- Market Expansion Strategy: This partnership not only strengthens Synchrony's influence in the home furnishings market but also consolidates its position in the furniture retail industry through collaboration with RH, which is expected to drive long-term growth for both parties.
- Cost Influences Decisions: According to Synchrony's survey, 55% of patients are more likely to choose optometrists offering payment options, highlighting the significant role of cost in vision care decisions, which impacts treatment choices and service utilization.
- Strong Demand for Financing: The study reveals that 80% of consumers would consider financing vision care expenses when costs reach approximately $761, and 44% of patients are willing to switch providers entirely for financial convenience, indicating a strong demand for financing options.
- Generational Divide: 78% of Gen Z report that cost impacts their vision care frequency, with 50% expressing interest in LASIK, yet only 5% are actual LASIK patients, illustrating the financial barriers faced by younger individuals.
- CareCredit Solution: The CareCredit credit card offers financing options for patients, with over 12 million open cardholder accounts and $40 billion in available credit, serving as a powerful tool for vision care providers to support patient access to necessary care.
- Financing Gap: The study reveals that 44% of patients are willing to switch vision providers for financial convenience, yet only 22% recall being offered financing options, indicating a significant gap that affects patient choices and treatment decisions in vision care.
- Cost Impact on LASIK: 59% of consumers cite cost as the primary reason for not proceeding with LASIK, surpassing concerns about surgical risks and negative outcomes, highlighting the critical role of pricing in patient decision-making and potential market losses.
- Gen Z Financing Needs: 78% of Gen Z consumers report that cost impacts their frequency of seeking vision care, with 50% expressing interest in LASIK, yet only 5% of LASIK patients are from this demographic, illustrating the financial barriers faced by this generation.
- Provider Opportunities: The research indicates that 43% of patients would be more likely to seek care if they could pay in installments, presenting an opportunity for vision providers to attract and retain patients through flexible payment options, ultimately enhancing long-term eye health and quality of life.










